Evekeo is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals. The primary component is Amphetamine Sulfate.
Product ID | 24338-022_1e24f7bd-651c-48c0-9c48-33a8624fc026 |
NDC | 24338-022 |
Product Type | Human Prescription Drug |
Proprietary Name | Evekeo |
Generic Name | Amphetamine Sulfate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-11-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA200166 |
Labeler Name | Arbor Pharmaceuticals |
Substance Name | AMPHETAMINE SULFATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2021-03-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA200166 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-11-01 |
Ingredient | Strength |
---|---|
AMPHETAMINE SULFATE | 5 mg/1 |
SPL SET ID: | f469fb38-0380-4621-9db3-a4f429126156 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
24338-022 | Evekeo | Amphetamine Sulfate |
24338-026 | Evekeo | Amphetamine Sulfate |
0406-1219 | Amphetamine Sulfate | Amphetamine Sulfate |
0406-1220 | Amphetamine Sulfate | Amphetamine Sulfate |
0527-2524 | AMPHETAMINE SULFATE | amphetamine sulfate |
0527-2525 | AMPHETAMINE SULFATE | amphetamine sulfate |
13107-259 | Amphetamine Sulfate | Amphetamine Sulfate |
13107-260 | Amphetamine Sulfate | Amphetamine Sulfate |
24338-031 | Evekeo ODT | AMPHETAMINE SULFATE |
24338-033 | Evekeo ODT | AMPHETAMINE SULFATE |
24338-035 | Evekeo ODT | AMPHETAMINE SULFATE |
24338-037 | Evekeo ODT | AMPHETAMINE SULFATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EVEKEO 86147416 4740064 Live/Registered |
Arbor Pharmaceuticals, LLC 2013-12-18 |